(narrating their own work) deliver a definitive exploration of moral injurythe silent epidemic ravaging veterans, health care workers, educators, and first responders
"If it's banned it must work, right?" So what do we do when patients are taking it anyway
Daniel Strbian: Scientific advisory board Boehringer-Ingelheim and Astra Zeneca E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2543 - ESOC25-1742 OLD ISCHEMIC LESIONS ON MRI IN THE EMERGENCY DEPARTMENT ASSOCIATED COMORBIDITIES OF ACUTE STROKE AND TIA VERSUS NON-STROKE CONDITIONS Malini Sagar 1,2 , Christian Krag 2,3,4 , Karen Lind Gandrup 3 , Mikael Boesen 2,4,5 , Christina Kruuse 1,2,6 1 Department of Neurology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark, 2 Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, 3 Department of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark, 4 Radiological AI Test Center (RAIT.dk), Copenhagen University Hospital - Herlev and Gentofte & Bispebjerg and Frederiksberg, Copenhagen, Denmark, 5 Department of Radiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark, 6 Department of Brain and Spinal Cord Injury, Copenhagen University Hospital - Rigshospitalet Glostrup, Glostrup, Denmark Background and Aims: Old ischemic lesions on magnetic resonance imaging (MRI), among patients without ischemic stroke or transitory ischemic attack (TIA), cause occasional therapeutic dilemmas
COSMAX has played a major role in this evolution by continuously experimenting with new ingredient technologies, carrier systems, and formulation techniques
